MEI Pharma

MEIP63

Penny Stock

$2.770.00%$0.00

Penny Stock

MEIP63

$2.77

0.00%$0.00

Penny Stock

Performance History

Key Stats
Open	$2.74
Prev. Close	$2.77
EPS	2.67

Next Earnings Date	-
Dividend Yield %	-
Market Cap	$18.05M

	LOW	HIGH
Day Range	2.65	2.79
52 Week Range	2.73	7.87

Ratios

Revenue	-





EPS	2.67

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About MEI Pharma (MEIP)

MEI Pharma Inc (NASDAQ: MEIP) is a pharmaceutical company that specializes in developing innovative therapies for cancer. The company is focused on advancing its pipeline of potential drugs that target various types of cancer, including acute myeloid leukemia (AML) and solid tumors. MEI Pharma's goal is to improve patient outcomes and provide new treatment options for those affected by cancer.

MEI Pharma's stock price history shows that it has experienced fluctuations over the years. Investors should carefully analyze the stock's performance before making investment decisions. It is important to consider factors such as market trends, company financials, and industry conditions when evaluating MEI Pharma's stock.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. David M. Urso B.A., Esq., J.D.
Headquarters: San Diego
Employees: 102
Exchange: NASDAQ

Keep an eye on MEI Pharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is MEI Pharma 's (MEIP) price per share?

The current price per share for MEI Pharma (MEIP) is $2.77. The stock has seen a price change of $0 recently, indicating a 0% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for MEI Pharma (MEIP)?

For MEI Pharma (MEIP), the 52-week high is $7.87, which is 183.6% from the current price. The 52-week low is $2.73, the current price is 1.65% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is MEI Pharma (MEIP) a growth stock?

MEI Pharma (MEIP) has shown an average price growth of -1.93% over the past three years. It has received a score of 6 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying MEI Pharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is MEI Pharma (MEIP) stock price performance year to date (YTD)?

As of the latest data, MEI Pharma (MEIP) has a year-to-date price change of -53.83%. Over the past month, the stock has experienced a price change of -7.5%. Over the last three months, the change has been -3.98%. Over the past six months, the figure is -16.16%. Looking at a longer horizon, the five-year price change stands at -92.25%.

help

Is MEI Pharma (MEIP) a profitable company?

MEI Pharma (MEIP) has a net income of $17.78M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 75.54% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 39.81% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 33.76%, providing insight into the company's sales performance and growth. The gross profit is $49.33M. Operating income is noted at $14.54M. Furthermore, the EBITDA is $36.72M.

help

What is the market capitalization of MEI Pharma (MEIP)?

MEI Pharma (MEIP) has a market capitalization of $18.06M. The average daily trading volume is 2.74, indicating the stock's liquidity and investor engagement.